Today’s stock pick update

Learn More 2 Years from Millions in Retirement? (See How) If you haven’t made your millions yet… and are worried that you won’t make yours in time before it’s time to retire… you’re in luck… [ad] Because others are turning relatively small amounts of money into millions in as little as just 18 to 24 months! AstraZeneca Shares Down After U.S. Says Company Included Outdated Information In COVID-19 Trial Data

AstraZeneca shares are down more than 3% this morning after a U.S. health agency said that the company may have included outdated information in trial results for its COVID-19 vaccine, casting a shadow over efficacy rates published yesterday. The Data Safety Monitoring Board “expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incom... Read More

CTI BioPharma Corp (NASDAQ: CTIC): CTI BioPharma shares rose as much as 29% yesterday after the company announced that Clinical Cancer Research, a journal of the American Association for Cancer Research, as published results from a Phase 1 study of pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, for the prevention of acute graft-versus-host disease (... Read More

KR might not be sexy – but it is still a terrific value The herd mentality is a big reason why pandemic-driven concerns since March have driven most of the market’s attention to stocks in the Technology and Healthcare sector. That doesn’t mean it’s wrong – but it’s one of the biggest reasons that a lot of tech stocks are now trading a valuations that even the most bullish, growth-focused analysts are finding hard to justify. Herd mentality that drives stocks to extreme highs is a manifestation of investor’s tendency to want to inve... Read More

Your Featured Stock Annovis Bio, Inc. (ANVS) – Buy Price: $38.00 or better Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company’s lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer’s disease (AD), Parkinson’s disease, Alzheimer’s disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical ... Read More

Other Top Stories US colleges tout hopes for return to new normal this fall Yellen, Powell say more needed to promote recovery Regal Cinemas, 2nd largest chain in US to reopen in April Prince Harry joins coaching startup as chief impact officer The top iPhone and iPad apps on App Store

Trend Following Picks Annovis Bio, Inc. (ANVS) – Buy Price: $38.00 or better Wyndham Hotels & Resorts, Inc. (WH) – Buy Price: $71.00 or better Cowen Inc. (COWN) – Buy Price: $41.00 or better Riot Blockchain, Inc. (RIOT) – Buy Price: $67.00 or better DICK’S Sporting Goods, Inc. (DKS) – Buy Price: $80.00 or better All Picks

Reversal Picks Impac Mortgage Holdings, Inc. (IMH) Buy Target $2.76 Sell Target $3.29 Companhia Energética de Minas Gerais (CIG) Buy Target $2.34 Sell Target $2.59 Jianpu Technology Inc. (JT) Buy Target $3.31 Sell Target $4.10 Document Security Systems, Inc. (DSS) Buy Target $4.43 Sell Target $5.47 Isoray, Inc. (ISR) Buy Target $1.60 Sell Target $2.06 All Picks

Low Price Stock Picks Weidai Ltd. (WEI) StoneMor Inc. (STON) Network-1 Technologies, Inc. (NTIP) Golden Star Resources Ltd. (GSS) China Pharma Holdings, Inc. (CPHI) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

 

This email was sent to phanhoa1821960.trader@blogger.com  from Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037  Unsubscribe  Disclaimers, Terms & Conditions | Privacy Policy Copyright 2020  Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.